[Possibilities and limitations of the use of rat paw edemas as models of inflammation. 1. Review on edemas as models and their possible use].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001920:Bradykinin / Q000494:pharmacology; D002351:Carrageenan / Q000494:pharmacology; D002464:Cell Migration Inhibition; D003911:Dextrans / Q000494:pharmacology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000139:chemically induced; D005528:Foot; D005557:Formaldehyde / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced; D007616:Kaolin / Q000494:pharmacology; D010047:Ovalbumin / Q000494:pharmacology; D011205:Povidone / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012441:Saccharomyces cerevisiae; D012701:Serotonin / Q000494:pharmacology; D013045:Species Specificity; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D005557:Formaldehyde; D007616:Kaolin; D012701:Serotonin; D003189:p-Methoxy-N-methylphenethylamine; D006632:Histamine; D002351:Carrageenan; D010047:Ovalbumin; D011205:Povidone; D001920:Bradykinin
Möglichkeiten und Grenzen der Verwendung von Rattenpfotenödemen als Entzündungsmodelle